CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $79.96 -12.53%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.44 better than the analyst estimate of $1.65. Revenue for the quarter came in at $108.4 billion versus the consensus estimate of $104.75 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $8.04.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Sun Life Financial (SLF) Tops Q3 EPS by 2c
- Summit Therapeutics (SMMT) Tops Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
